Vielversprechende Daten mit Dostarlimab beim fortgeschrittenen Endometriumkarzinom
Crossref DOI link: https://doi.org/10.1007/s15015-021-3523-2
Published Online: 2021-06-28
Published Print: 2021-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ortner, Petra
Text and Data Mining valid from 2021-06-01
Version of Record valid from 2021-06-01
Article History
First Online: 28 June 2021
Free to read: This content has been made available to all.